As of today, the European Medicines Agency (EMA) gives open access to clinical reports for new medicines for human use authorised in the European Union (EU).
Vytenis Andriukaitis, European Commissioner for Health and Food Safety, said “Transparency is an essential component in clinical research. Its outcome – whether positive or negative – should be made publicly available. EMA’s transparency initiative will make Europe a true front runner with respect to release of data concerning clinical trials. It will create a bridge from now until the new Clinical Trials Regulation – which foresees additional milestones towards transparency, becomes applicable.”